Thursday, May 16, 2024
Home Client Page 5

Client

    Random

    Mitesco (MITI) Sets Opening Dates for New Minneapolis Clinics, Additional Sites in Minneapolis and...

    Telehealth Editor / Curator -
    MINNEAPOLIS, MN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTCQB:MITI) ("Mitesco" or the "Company"), a leading operator of wellness clinics...

    Initiating Coverage on Society Pass (SOPA).

    Featured Editor / Curator -
    Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley
    Citius Pharma

    Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.

    Biotech News Editor / Curator -
    STREET INSIDER H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...

    Real Estate Wonder Redefy to go Public. Full-Service Real Estate Transactions for $3,500 Flat...

    Traveltech Editor / Curator -
    Redefy Holdings, Inc., Enters into Definitive Share Exchange Agreement to Become a Publicly Traded Company DENVER, March 12,...

    Is Citius Pharma a Ten Bagger?

    Biotech News Editor / Curator -
    As is From $0.80 to $8.00.. One of our favorite Broker/Dealer Analysts thinks it is..

    Meet Dennis Nguyen CEO of Start-Up Investor, the Society Pass (Symbol: SOPA)

    Client Editor / Curator -
    See a Dazzling Presentation! Society Pass (SOPA) has quickly acquired 8 companies since going public in late 2021,...
    ecuador gold

    Ecuador: The Largest Gold Rush in History? Initiating Coverage on Lucky Minerals (LKMNF).

    Precious Metals Editor / Curator -
    Bonafide Gold Rush in Ecuador as the World’s Biggest Miners Race to Stake Claims in the Largest Land Grab in Gold...
    Citius Pharma

    Citius Pharma (CTXR) On The Move.

    2020 Watch List Editor / Curator -
    One Of Our Top 5 Biotech Picks For 2020 Up 23% Yesterday, Indicating Up Another 24% This Morning. Inquiring Minds Want...

    Society Pass (SOPA) Research Reports

    Research Editor / Curator -
    RESEARCH REPORT ARCHIVE December 27th, 2023. Litchfield Hills Research - $4.00 Price Target.
    Cyclophilin, Biotech Stock Review

    Adding Hepion Pharma (HEPA) $1.73 to Watch List.

    Biotech News Editor / Curator -
    Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here? Oh my…and Oh boy....
    1...456...36Page 5 of 36

    Latest article

    Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

    2022 Watch List Editor / Curator -
    When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

    GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

    Client Editor / Curator -
    Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

    NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

    Client Editor / Curator -
    Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.